Hypotension during hemodialysis: Role for nitric oxide

American Journal of the Medical Sciences

Volumn 313, Issue 3, 1997, Pages 138-146

  Kang, Ellen S ^a   Acchiardo, Sergio R ^a   Wang, Yu Bo ^a   Tevlin, Marjorie T ^a   Hughes, Thomas ^a   Cardoso, Sergio ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Greiss method; Hemodialysis; Hypotension; Nitric oxide; Nitrite and Nitrate

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; HEMODIALYSIS; HUMAN; HYPOTENSION; KIDNEY FAILURE; SKIN TEMPERATURE; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

EID: 0030998150     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199703000-00003     Document Type: Article

References (32)

1. Henderson LW. Symptomatic hypotension during dialysis. Kidney Int. 1980;17:571-6.
2. Henrich WL. Hemodynamic instability during hemodialysis. Kidney Int. 1986;30:605-12.
3. Converse RL Jr, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. New Eng J Med. 1992;327:1912-8.
4. Daugirdas JT. Dialysis hypotension: A hemodynamic analysis. Kidney Int. 1991;39:233-46.
5. Leunissen KML, Noordzu TC, van Hooff JP. Pathophysi- ologic aspects of plasma volume preservation. Contrib Nephrol. 1990;78:201-11.
6. Nies AS, Robertson D, Stone WJ. Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy. J Lab Clin Med. 1979;94:395-402.
7. Malik S, Winney RJ, Ewing DJ. Chronic renal failure and cardiovascular autonomic function. Nephron. 1986;43:191-5.
8. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-64.
9. Moncada S. The L-arginine-nitric oxide pathway. New Engl J Med. 1993;329:2002-10.
10. Morris SM Jr, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 1994;266:E829-39.
11. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nature Medicine. 1995;1:804-9.
12. Dinarello CA. Cytokines: Agents provocateurs in hemodialysis? Kidney Int. 1992;41:683-94.
13. Lazarus JM, Owen WF. Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis. 1994;24:1019-32.
14. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension. The interleukin hypothesis. Blood Purif. 1983;1:3-8.
15. Port FK, VanDeKerkhove KM, Kunkel SL, Kluger MJ. The role of dialysate in the stimulation of interleukin-l production during clinical hemodialysis. Am J Kidney Dis. 1987;10:118-22.
16. Dinarello CA, Koch KK, Shaldon S. Interleukin-1 and its relevance in patients treated with hemodialysis. Kidney Int. 1988;33:S21-6.
17. Beasley D, Brenner BM. Role of nitric oxide in hemodialysis hypotension. Kidney Int. 1992;42:S96-100.
18. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, et al. Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med. 1995;123:35-7.
19. Jindal KK, Goldstein MB. Urea kinetic modelling in chronic hemodialysis: Benefits, problems, and practical solutions. Seminars in Dialysis. 1988;1:82-5.
20. 15N]nitrate in biological fluids. Analytical Biochemistry 1982;126:131-8.
21. Luger A, Kovarik J, Stummvoll HK, Urbanska A, Luger T. Blood membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int. 1987;32:84-8.
22. Dinarello CA. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int. 1992;42:S68-77.
23. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int. 1990;37:116-25.
24. Lonnemann G, Behme TC, Lenzner B, Floege J, Schulze M, Colton CK, Koch KM, Shaldon S. Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria. Kidney Int. 1992;42:61-8.
25. Pfeilshifter J, Rob P, Mulsch A, Fandrey J, Vosbeck K, Busse R. Interleukin 1β and tumour necrosis factor α induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem. 1992;203:251-5.
26. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest. 1992;90:1718-25.
27. Shultz PJ, Tolins JP. Adaptation to increased dietary salt intake in the rat. Role of endogenous nitric oxide. J Clin Invest. 1993;91:642-50.
28. Wennmalm A. Metabolism and excretion of nitric oxide in man: Basal studies and clinical applications. Basel, Birkhauser Verlag, Mediators in the Cardiovascular System. Regional Ischemia. 1995:129-138.
29. Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 1996;380:221-6.
30. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 1992;89:7674-7.
31. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-5.
32. Vallance P, Leone A, Calver A, Collier J, Moncada S, Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol. 1992;20:S60-2.